Celsion Corporation [NASDAQ: CLSN] closed the trading session at $2.45 on 02/12/21. The day’s price range saw the stock hit a low of $2.26, while the highest price level was $2.65. The company report on February 12, 2021 that Celsion Corporation Announces Formation of Vaccine Advisory Board.
Board to provide guidance in developing the PLACCINE platform for the prevention and treatment of infectious agents, including SARS-CoV-2.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
Celsion Corporation (NASDAQ: CLSN), an oncology drug development company, announced the formation of a Vaccine Advisory Board and the appointment of its first two members:.
The stocks have a year to date performance of 244.59 percent and weekly performance of 42.44 percent. The stock has been moved at 124.77 percent over the last six months. The stock has performed 167.32 percent around the most recent 30 days and changed 371.24 percent over the most recent 3-months.
If compared to the average trading volume of 11.80M shares, CLSN reached to a volume of 40515876 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Celsion Corporation [CLSN]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CLSN shares is $4.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CLSN stock is a recommendation set at 2.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Oppenheimer have made an estimate for Celsion Corporation shares, keeping their opinion on the stock as Perform, with their previous recommendation back on July 16, 2020. The new note on the price target was released on July 14, 2020, representing the official price target for Celsion Corporation stock. Previously, the target price had yet another raise to $7, while Maxim Group analysts kept a Buy rating on CLSN stock.
The Average True Range (ATR) for Celsion Corporation is set at 0.36, with the Price to Sales ratio for CLSN stock in the period of the last 12 months amounting to 284.40. The Price to Book ratio for the last quarter was 4.45.
CLSN stock trade performance evaluation
Celsion Corporation [CLSN] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 42.44. With this latest performance, CLSN shares gained by 167.32% in over the last four-week period, additionally plugging by 124.77% over the last 6 months – not to mention a rise of 82.84% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CLSN stock in for the last two-week period is set at 72.46, with the RSI for the last a single of trading hit 74.56, and the three-weeks RSI is set at 71.05 for Celsion Corporation [CLSN]. The present Moving Average for the last 50 days of trading for this stock 1.09, while it was recorded at 2.21 for the last single week of trading, and 1.40 for the last 200 days.
Celsion Corporation [CLSN]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and Celsion Corporation [CLSN] shares currently have an operating margin of -4113.09. Celsion Corporation’s Net Margin is presently recorded at -3370.31.
Return on Total Capital for CLSN is now -73.22, given the latest momentum, and Return on Invested Capital for the company is -62.48. Return on Equity for this stock declined to -95.15, with Return on Assets sitting at -39.59. When it comes to the capital structure of this company, Celsion Corporation [CLSN] has a Total Debt to Total Equity ratio set at 77.86. Additionally, CLSN Total Debt to Total Capital is recorded at 43.77, with Total Debt to Total Assets ending up at 29.61. Long-Term Debt to Equity for the company is recorded at 62.55, with the Long-Term Debt to Total Capital now at 35.17.
Reflecting on the efficiency of the workforce at the company, Celsion Corporation [CLSN] managed to generate an average of -$581,087 per employee. Receivables Turnover for the company is 11.15 with a Total Asset Turnover recorded at a value of 0.01.Celsion Corporation’s liquidity data is similarly interesting compelling, with a Quick Ratio of 3.70 and a Current Ratio set at 3.70.
Earnings per share (EPS) analysis for Celsion Corporation [CLSN] stock
With the latest financial reports released by the company, Celsion Corporation posted -0.1/share EPS, while the average EPS was predicted by analysts to be reported at -0.2/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 50.00%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CLSN.
Celsion Corporation [CLSN]: Insider Ownership positions
There are presently around $12 million, or 10.70% of CLSN stock, in the hands of institutional investors. The top three institutional holders of CLSN stocks are: VANGUARD GROUP INC with ownership of 1,265,670, which is approximately -0.323% of the company’s market cap and around 1.25% of the total institutional ownership; BLACKROCK INC., holding 709,245 shares of the stock with an approximate value of $1.74 million in CLSN stocks shares; and MORGAN STANLEY, currently with $1.65 million in CLSN stock with ownership of nearly 161355.263% of the company’s market capitalization.
Positions in Celsion Corporation stocks held by institutional investors increased at the end of March and at the time of the March reporting period, where 19 institutional holders increased their position in Celsion Corporation [NASDAQ:CLSN] by around 1,918,028 shares. Additionally, 14 investors decreased positions by around 667,449 shares, while 14 investors held positions by with 2,414,124 shares. The mentioned changes placed institutional holdings at 4,999,601 shares, according to the latest SEC report filing. CLSN stock had 5 new institutional investments in for a total of 251,105 shares, while 7 institutional investors sold positions of 381,202 shares during the same period.